How to Identify High-Growth Stocks Trading at Reasonable Valuations

Eighteen point nine percent. That is the average 12-month gain columnist John Dorfman reports on his previous nineteen selections of stocks combining growth and value characteristics, against a 12.6% baseline for the S&P 500 Total Return Index over the same windows. Three separate outlets this week ran the same essential filter — buy earnings growth, refuse to overpay — and the resulting lists overlap just enough to deserve your attention.

The filter that actually has teeth

Most "growth at a reasonable price" screens die on Wall Street marketing. They tilt on revenue multiples that mean nothing to a disciplined investor, or they substitute one-year earnings momentum for the durable kind. The screen running through this week's pieces is sterner. Dorfman's version, published by TribLIVE, draws a hard line: a value stock trades at no more than 15 times trailing per-share profits, and a growth stock has compounded earnings at 15% or better over the prior five years. Advisor Perspectives, via FAST Graphs, applied a similar logic across twenty names. 24/7 Wall St. ran a narrower list aimed at a 2030 horizon.

This is not a vibes-based exercise. The math is asymmetric. You are screening for two variables — price and earnings power — and rejecting anything that fails either test. Yield drag evaporates. Multiple compression risk is already partly priced out. What remains is execution risk, not valuation risk — and that is a category where research can actually earn its keep.

The names that cleared both bars

Dorfman's published picks give us five concrete examples worth stress-testing against your own portfolio. Progressive (PGR) carries a five-year earnings growth rate above 24% and trades near 11 times earnings, with a telematics-driven underwriting edge. EOG Resources, the old Enron Oil & Gas spinoff, has compounded earnings above 34% annually and trades around 12 times earnings, with a reputation for conservative accounting. Axos Financial (AX), an internet-only bank based in Las Vegas, sits near 11 times earnings with a five-year growth rate just over 19%, though it carries a Hindenburg short-seller report from June 2024 that the market has so far dismissed. Deckers Outdoor (DECK), the parent of Ugg and Hoka, grows earnings at roughly 28% but trades at only 13 times earnings. Green Brick Partners (GRBK), a homebuilder chaired by David Einhorn, has had four rough quarters with profits down 15% on a 4% revenue decline, yet the five-year growth rate remains above 26% and the multiple sits at 11 times earnings.

Run your own if/then scenarios. If the homebuilder cycle extends, GRBK's depressed trailing earnings understate normalized power. If Progressive's combined ratio deteriorates, that 11x multiple becomes a trap. If Axos's commercial real estate exposure turns toxic, the screen stops protecting you. The framework does not eliminate risk. It transfers risk from valuation — where you have no edge — to cycle timing and execution, where your work can actually compound.

The discipline this demands

Here is where the marketing fails you and where your edge begins. A list of twenty names, or five, or three, is not a portfolio. It is a starting universe. Your job is to take each name, model normalized earnings power, stress-test the cycle, and decide whether the current multiple compensates you for the specific risks that name carries. If you cannot articulate why a stock passes your screen in one sentence, it does not pass.

The binary choice is straightforward. You can chase narratives and accept that your returns will track whatever the index gives you, or you can run the same filter these analysts ran, layer your own judgment on cycle and execution, and accept that your edge comes from discipline, not prediction. Dorfman's eighteen point nine percent is not luck. It is the compound return on refusing to overpay for growth that compounds.